PERSEUS: Preliminary Efficacy and Safety of Cenicriviroc in Adult Participants With Primary Sclerosing Cholangitis
Status:
Completed
Trial end date:
2017-08-31
Target enrollment:
Participant gender:
Summary
This is an open label, proof of concept (PoC) study of Cenicriviroc (CVC) in adult
participants with Primary Sclerosing Cholangitis (PSC). The main objective of this PoC study
is to assess changes in alkaline phosphatase (ALP) both individually and as a group, over 24
weeks of treatment with CVC.